Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is specifically designed for hematologists/oncologists, internists, nurses, pharmacists, and other healthcare professionals with an interest and/or involvement in hematologic malignancies.
Objectives
After successful completion of this course, attendees should be able to:
- Discuss the most clinically relevant data presented at the 51st Annual Hematology Meeting
- Analyze emerging data on multiple hematologic malignancies and benign abnormalities in order to improve patient outcomes
- Explain the limitations and benefits of new and emerging therapies for the treatment of patients with benign and malignant hematologic conditions
- Incorporate emerging data into the clinical management of patients with benign and malignant hematologic conditions
- Discuss ways in which current clinical practice should be modified based on the latest advances in hematology
Stephen A. Ansell, MD, PhD
Mayo Clinic
Rochester, Minnesota
Leif Bergsagel, MD
Mayo Clinic
Rochester, Minnesota
Marcel P. Devetten, MD
University of Nebraska Medical Center
Omaha, Nebraska
Ruben Mesa, MD
Mayo Clinic
Scottsdale, Arizona
David P. Steensma, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
Moshe Talpaz, MD
University of Michigan
Ann Arbor, Michigan
Parameswaran Venugopal, M.D.
Rush University Medical Center
Chicago, Illinois
Moderator:
Jim Epstein, MD
7:00 AM
Breakfast buffet and registration
8:00 AM
Welcome and introduction
Jim Epstein, MD
8:15 AM
Multiple Myeloma Abstracts
Leif Bergsagel, MD, Mayo Clinic, Rochester, Minnesota
9:00 AM
Q&A
9:15 AM
Chronic Lymphocytic Leukemia Abstracts
Parameswaran Venugopal, M.D., Rush University Medical Center, Chicago, Illinois
9:45 AM
Q&A
10:00 AM
Break
10:20 AM
Myelodysplastic Syndromes Abstracts
David P. Steensma, MD, Dana-Farber Cancer Institute, Boston, Massachusetts
10:50 AM
Q&A
11:05 AM
Chronic Myelogenous Leukemia Abstracts
Moshe Talpaz, MD, University of Michigan, Ann Arbor, Michigan
11:50 PM
Q&A
12:05 PM
Lunch
1:05 PM
Acute Leukemia Abstracts
Marcel P. Devetten, MD, University of Nebraska Medical Center, Omaha, Nebraska
.
1:35 PM
Q&A
1:50 PM
Lymphomas Abstracts
Stephen A. Ansell, MD, PhD, Mayo Clinic, Rochester, Minnesota
2:35 PM
Q&A
2:50 PM
Break
3:10 PM
Myeloproliferative Neoplasm Abstracts
Ruben Mesa, MD, Mayo Clinic, Scottsdale, Arizona
3:40 PM
Q&A
4:00 PM
Adjourn
Registration Fees
Physicians........................................$99.00
Nurses/Residents/Students*..........$45.00
*proof of eligibility must accompany registration
Pharmaceutical Industry................$175.00
Registration Procedures
To Register:You may register online up to 5 business days before the meeting at www.imedex.com, by calling Imedex at +1 (678) 242 0906, or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
Payment: To pre-register, registration and payment must be received no later than 5 business days before the meeting. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 5 business days before the meeting. The amount of registration fees remitted, minus a $25 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 5 business days before the meeting.
Imedex does not accept responsibility for covering travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation.The event agenda is subject to change without notice.
January 23, 2010 – Chicago, Illinois
Omni Chicago Hotel
676 North Michigan Avenue
Chicago, Illinois 60611
Tel: +1 (312) 944 6664
Website: www.omnihotels.com/FindAHotel/Chicago.aspx
Rate: $159.00 + 15.4% tax
Hotel registration deadline: January 1, 2010
For the convenience of attendees, a limited number of rooms have been reserved at the conference hotel along with a discounted rate as noted above. The discounted rate is only available until the hotel deadline dates noted above. This rate is not guaranteed outside the conference dates or after the hotel deadline dates. To reserve your room please contact the hotel reservations department at the phone number above or visit the hotel’s website. To receive the group rate, callers must identify themselves as being with the Hematology 2010 group. Reservation requests received after the hotel deadline dates as noted above may not be guaranteed the group rate.
ORGANIZER
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies has provided an educational grant in support of this conference:
SILVER
Genentech BioOncology
& Biogen Idec
BRONZE
CORPORATE
Several options are available to companies interested in supporting this conference. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.
